GO:1905314 semi-lunar valve development: Morphogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905314 (semi-lunar valve development) describes the biological process by which the semilunar valves (aortic and pulmonary) progress from formation to mature structure.
• Semilunar valve development is critical for unidirectional blood flow and is clinically linked to congenital heart defects and valve disease.
• Key genes include NOTCH1, GATA4, GATA6, NKX2-5, TBX20, and others, many identified through human genetics and animal models.
• Murine models are essential for studying semilunar valve development, with functional mechanical behavior characterized in pulmonary valves.
• Tissue engineering approaches, including elastomeric scaffolds with curvilinear fibrous structures, aim to replicate native valve leaflet architecture.
• CRISPR-based knockout, knock-in, and overexpression models enable causal testing of candidate genes in semilunar valve development.
Description
Semi-lunar valve development (GO:1905314) is the biological process whose specific outcome is the progression of a semi-lunar valve over time, from its formation to the mature structure. The semilunar valves, comprising the aortic and pulmonary valves, are essential for preventing backflow from the great arteries into the ventricles, and their proper development is required for normal cardiac function. Disruptions in this process can lead to congenital heart defects such as bicuspid aortic valve and pulmonary stenosis, making it a critical area of research. Understanding the molecular and cellular mechanisms of semilunar valve development is therefore vital for diagnosing, preventing, and treating valve-related diseases. This article synthesizes current knowledge on the genes, regulatory pathways, and experimental models used to study this process, with a focus on CRISPR-based approaches for functional validation.
semi-lunar valve development At A Glance
| GO ID | GO:1905314 |
|---|---|
| GO term | semi-lunar valve development |
| Ontology | biological_process |
| Synonym | semilunar valve development; semilunar valves development |
| Major function | Progression of semilunar valves from formation to mature structure |
| Related anatomy | Aortic valve, pulmonary valve |
| Associated diseases | Congenital heart defects, bicuspid aortic valve, pulmonary stenosis |
| Key research models | Mouse, zebrafish, cell culture, tissue engineering |
What Is GO:1905314?
GO:1905314, semi-lunar valve development, is defined as the process whose specific outcome is the progression of a semi-lunar valve over time, from its formation to the mature structure. This encompasses the morphological, cellular, and molecular events that transform early embryonic valve primordia into fully functional aortic and pulmonary valves, including endocardial cushion formation, valve leaflet remodeling, and extracellular matrix organization.
Why Is semi-lunar valve development Important in Cell Biology?
Semi-lunar valve development is essential for establishing unidirectional blood flow and normal cardiac function. Defects in this process are among the most common congenital heart anomalies, and understanding its mechanisms can inform diagnostic and therapeutic strategies. Research into semilunar valve development also guides tissue engineering efforts to create replacement valves with biomimetic properties.
• Congenital heart defects affecting semilunar valves are a major cause of morbidity and mortality.
• Proper semilunar valve development ensures unidirectional flow and prevents regurgitation.
• Genetic mutations in valve development genes are linked to familial and sporadic valve disease.
• Animal models, especially murine, provide insights into functional mechanical behavior of pulmonary valves.
• Tissue engineering of valve leaflets requires understanding of native fibrous structure.
• CRISPR screening can identify novel regulators of semilunar valve development.
• Valve development research informs percutaneous valve replacement strategies.
• In utero evolution of heart disease highlights the clinical relevance of valve development.
What Happens During semi-lunar valve development?
Endocardial Cushion Formation
In simple terms: The initial step where cells in the heart tube cluster to form primitive valve structures.
During early embryogenesis, endocardial cells undergo endothelial-to-mesenchymal transition (EndMT) and migrate into the cardiac jelly to form endocardial cushions, the precursors of semilunar valves. This process is regulated by signaling pathways including Notch, TGF-beta, and Wnt.
Valve Leaflet Remodeling
In simple terms: The cushions are sculpted into thin, flexible leaflets.
After cushion formation, the primitive valves undergo remodeling, involving apoptosis, cell proliferation, and extracellular matrix reorganization, to form mature leaflets with distinct layers (fibrosa, spongiosa, ventricularis). This step is critical for valve durability and function.
Extracellular Matrix Organization
In simple terms: The valve leaflets get their strength and flexibility from a specialized matrix.
The extracellular matrix (ECM) of semilunar valves is composed of collagen, elastin, and proteoglycans, organized into stratified layers that provide tensile strength and elasticity. Proper ECM organization is essential for valve function, and its disruption leads to valve disease.
Functional Maturation
In simple terms: The valve becomes fully functional and responsive to blood flow.
As the valve matures, it acquires the ability to withstand hemodynamic forces and regulate blood flow. Mechanical behavior of murine pulmonary valves has been characterized, showing anisotropic properties that are critical for function.
Key Genes Involved in GO:1905314 semi-lunar valve development
Numerous genes have been implicated in semi-lunar valve development through human genetics and animal models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NOTCH1 | Signaling in EndMT and valve remodeling | Mutations linked to bicuspid aortic valve |
| GATA4 | Transcription factor regulating valve development | Associated with congenital heart defects |
| GATA6 | Transcription factor in valve morphogenesis | Mutations in tetralogy of Fallot |
| NKX2-5 | Homeobox transcription factor | Essential for cardiac development |
| TBX20 | T-box transcription factor | Regulates valve formation |
| BMP2 | Signaling molecule in EndMT | Critical for cushion formation |
| BMP4 | Signaling in valve development | Involved in outflow tract septation |
| TGFBR1 | TGF-beta receptor | Mediates EndMT |
| TGFBR2 | TGF-beta receptor | Regulates valve remodeling |
| SMAD4 | TGF-beta signaling mediator | Central to valve development |
| VEGFA | Angiogenic factor | Affects valve endothelial cells |
| NFATC1 | Transcription factor | Regulates valve elongation |
| SOX9 | Transcription factor | Involved in valve chondrogenesis |
| ELN | Elastin | ECM component of valve leaflets |
| COL1A1 | Collagen type I | ECM structural protein |
| COL3A1 | Collagen type III | ECM structural protein |
| HAS2 | Hyaluronan synthase 2 | ECM remodeling |
How Is semi-lunar valve development Regulated?
Semi-lunar valve development is regulated by a complex network of signaling pathways, including Notch, TGF-beta/BMP, Wnt, and VEGF. These pathways control endothelial-to-mesenchymal transition, cell proliferation, apoptosis, and extracellular matrix remodeling. Hemodynamic forces also play a role in valve maturation, influencing gene expression and tissue organization.
semi-lunar valve development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOTCH1 | Bicuspid aortic valve | Knockout mouse, iPSC-derived valve cells |
| GATA4 | Congenital heart defects | Point mutation knock-in mouse |
| NKX2-5 | Tetralogy of Fallot | Overexpression in zebrafish |
| ELN | Supravalvular aortic stenosis | Knockout mouse |
| COL3A1 | Ehlers-Danlos syndrome | Knock-in mouse |
Congenital Heart Defects
Disruptions in semi-lunar valve development can lead to congenital heart defects such as bicuspid aortic valve, pulmonary stenosis, and tetralogy of Fallot. These conditions often require surgical or percutaneous intervention.
Valve Calcification and Stenosis
Abnormal valve development may predispose to calcific aortic valve disease later in life, characterized by progressive fibrosis and calcification. Understanding developmental mechanisms can inform prevention strategies.
Tissue Engineering and Regenerative Medicine
Knowledge of native valve structure and development guides the design of tissue-engineered heart valves, such as elastomeric scaffolds with curvilinear fibrous structures.
From semi-lunar valve development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate EndMT? | Knockout mouse or zebrafish |
| Does mutation Y cause valve stenosis? | Point mutation knock-in mouse |
| Can gene Z rescue valve defect? | Overexpression transgenic mouse |
| Where is protein A localized during valve development? | Tagged knock-in (e.g., GFP) mouse |
| What is the effect of gene W on valve ECM? | Conditional knockout in valve endocardium |
| Can CRISPR screen identify novel valve genes? | Pooled CRISPR library in cell culture |
How to Study the semi-lunar valve development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Histology | Tissue morphology | Valve structure analysis |
| Immunofluorescence | Protein localization | EndMT markers |
| RNA-seq | Transcriptome | Gene expression profiling |
| Mechanical testing | Tissue stiffness | Valve functional properties |
| Scaffold fabrication | Fibrous structure | Tissue engineering |
| CRISPR screening | Gene function | Novel regulator discovery |
| Lineage tracing | Cell origin | Valve cell fate mapping |
Histology and Immunostaining
Tissue sections can be stained to visualize valve morphology and protein expression during development.
Lineage Tracing
Genetic lineage tracing in mice using Cre-lox systems identifies the origin of valve cells.
Mechanical Testing
Biomechanical testing of murine pulmonary valves reveals functional properties such as stiffness and anisotropy.
Tissue Engineering
Fabrication of elastomeric scaffolds with curvilinear fibrous structures mimics native valve leaflet architecture for regenerative approaches.
How CRISPR Can Be Used to Study GO:1905314 semi-lunar valve development
Knockout
CRISPR knockout of candidate genes in mouse or cell models can determine their necessity for semilunar valve development. For example, knocking out NOTCH1 leads to valve defects.
Point Mutation
Introducing specific point mutations (e.g., in GATA4) via CRISPR knock-in can model human congenital heart defects and test causality.
Knock-in
Tagged knock-in (e.g., GFP) allows visualization of protein localization and dynamics during valve development.
Overexpression
CRISPR activation or transgenic overexpression can test sufficiency of a gene to drive valve development or rescue defects.
How EDITGENE Supports semi-lunar valve development Research
Researchers studying semi-lunar valve development-related genes often need to determine whether a candidate gene is causally involved in valve morphogenesis or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this functional validation.
Contact EDITGENE today to design your custom CRISPR model for semi-lunar valve development research.
Frequently Asked Questions About semi-lunar valve development
What is GO:1905314?
GO:1905314 is the Gene Ontology term for semi-lunar valve development, the process by which semilunar valves progress from formation to mature structure.
What genes are involved in semi-lunar valve development?
Key genes include NOTCH1, GATA4, GATA6, NKX2-5, TBX20, BMP2, BMP4, and TGFBR1/2, among others.
What diseases are associated with semi-lunar valve development?
Defects can cause bicuspid aortic valve, pulmonary stenosis, and tetralogy of Fallot.
How is semi-lunar valve development studied?
Common methods include histology, lineage tracing, mechanical testing, and CRISPR screens.
What animal models are used for semi-lunar valve development?
Mouse and zebrafish are widely used, with murine pulmonary valve mechanics characterized.
Can CRISPR be used to study semi-lunar valve development?
Yes, CRISPR knockout, knock-in, and overexpression models enable functional studies of candidate genes.
What is the role of NOTCH1 in semilunar valve development?
NOTCH1 signaling regulates endothelial-to-mesenchymal transition and valve remodeling; mutations are linked to bicuspid aortic valve.
How does tissue engineering relate to semilunar valve development?
Understanding native valve structure guides the design of scaffolds with curvilinear fibrous structures.
What is the clinical relevance of semilunar valve development?
It informs diagnosis and treatment of congenital heart defects and valve disease.
What are the layers of a mature semilunar valve leaflet?
The fibrosa, spongiosa, and ventricularis layers, each with distinct ECM composition.
Conclusion
Semi-lunar valve development (GO:1905314) is a complex, tightly regulated process essential for cardiac function. Research using genetic models and CRISPR technologies continues to uncover the molecular players involved, offering hope for new therapies for valve disease. EDITGENE supports these efforts with tailored CRISPR services.
References
- 1. Trines J et al.. 2004. Evolution of heart disease in utero.. Pediatr Cardiol 25(3):287-98 PMID: 15360119
- 2. Feng X et al.. 2023. Functional mechanical behavior of the murine pulmonary heart valve.. Sci Rep 13(1):12852 PMID: 37553466
- 3. Hobson CM et al.. 2015. Fabrication of elastomeric scaffolds with curvilinear fibrous structures for heart valve leaflet engineering.. J Biomed Mater Res A 103(9):3101-6 PMID: 25771748
- 5. Boudjemline Y et al.. 2005. Steps toward the percutaneous replacement of atrioventricular valves an experimental study.. J Am Coll Cardiol 46(2):360-5 PMID: 16022968
